New to Meducation?
Sign up
Already signed up? Log In
view moderators

Rheumatology

Category

Preview
1
26

Psoriatic Arthritis. What is psoriatric arthritis? Information | Patient

Synonyms: psoriatic arthropathy, arthropathia psoriatica, arthritis mutilans, seronegative arthritis associated with psoriasis See also separate articles...  
Patient.co.uk
over 4 years ago
Preview
1
23

Gout | Doctor | Patient

Gout can be defined as arthritis due to deposition of monosodium urate (MSU) monohydrate crystals within joints causing acute inflammation and eventual...  
Patient.co.uk
over 4 years ago
Preview
1
26

Calcium Pyrophosphate Deposition - including Pseudogout | Doctor | Patient

Pseudogout is an inflammation of joints caused by the deposition of calcium pyrophosphate (CPP) crystals in articular and periarticular tissues. It is...  
Patient.co.uk
over 4 years ago
Preview
1
34

Reactive Arthritis. Information about Reactive Arthritis | Patient

Reactive Arthritis is also known as Reiter's syndrome. Reactive arthritis is an autoimmune condition that develops in response to an infection.  
Patient.co.uk
over 4 years ago
Preview
1
42

Juvenile Idiopathic Arthritis. JIA information | Patient

Juvenile Idiopathic Arthritis can be known as Still's disease, juvenile arthritis, juvenile chronic arthritis, juvenile rheumatoid arthritis. More about Juvenile Idiopathic Arthritis (JIA)  
Patient.co.uk
over 4 years ago
Preview
1
142

Ankylosing Spondylitis AS. Inflamed spine information. Patient | Patient

Ankylosing Spondylitis known as rheumatoid spondylitis,, von Bechterew's disease; Ankylosing spondylitis (AS); Marie strumpell disease. Ankylosing Spondylitis is an inflamed spine  
Patient.co.uk
over 4 years ago
Www.bmj
1
10

Temporomandibular disorders

TMDs represent a range of conditions with multifactorial complex pathophysiology, which are common up to the age of 40 years  
bmj.com
over 4 years ago
Www.bmj
1
40

Drug treatments for rheumatoid arthritis: looking backwards to move forwards

Over the past 40 years the clinical picture has improved for patients with rheumatoid arthritis thanks to key steps in drug development and care strategy. These steps include the introduction of methotrexate in 1980 and the first inhibitors of tumour necrosis factor (TNF) in 2000. This was followed by the development of new biotechnology products to target other cytokines, cell subsets, and cell interaction pathways. All these products are expensive drugs with obvious consequences for health systems with limited resources.  
bmj.com
over 4 years ago
Www.bmj
1
11

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 4 years ago
Www.bmj
1
17

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 4 years ago
Www.bmj
1
3

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 4 years ago
Www.bmj
2
48

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 4 years ago
Www.bmj
1
7

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 4 years ago
Www.bmj
1
40

A sinister cause of shoulder pain, with numbness and weakness in the ipsilateral hand

A 41 year old patient with insulin dependent diabetes presented with a one month history of progressively worsening pain, numbness, and weakness of his right shoulder and arm. His history included peripheral vascular disease, chronic renal failure, and chronic pancreatitis. He was also a smoker with a 60 pack year history.  
bmj.com
over 4 years ago
Www.bmj
1
13

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 4 years ago
Www.bmj
1
4

Temporomandibular disorders

TMDs represent a range of conditions with multifactorial complex pathophysiology, which are common up to the age of 40 years  
bmj.com
over 4 years ago
Www.bmj
1
10

Drug treatments for rheumatoid arthritis: looking backwards to move forwards

Over the past 40 years the clinical picture has improved for patients with rheumatoid arthritis thanks to key steps in drug development and care strategy. These steps include the introduction of methotrexate in 1980 and the first inhibitors of tumour necrosis factor (TNF) in 2000. This was followed by the development of new biotechnology products to target other cytokines, cell subsets, and cell interaction pathways. All these products are expensive drugs with obvious consequences for health systems with limited resources.  
bmj.com
over 4 years ago
Www.bmj
1
11

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 4 years ago
Www.bmj
1
6

Temporomandibular disorders

TMDs represent a range of conditions with multifactorial complex pathophysiology, which are common up to the age of 40 years  
bmj.com
over 4 years ago
Preview
2
39

Starch Fermentation In the Digestive Tract

Video was part of 2014 Summer Scholarship Project with CSIRO called "The Hungry Microbiome" For more visit: http://www.csiro.au/hungrymicrobiome/ https://www...  
YouTube
over 4 years ago